The global acetazolamide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Acetazolamide is a carbonic anhydrase inhibitor used to treat chronic simple (open-angle) glaucoma, secondary glaucoma, acute angle-closure glaucoma, epilepsy, edoema from congestive heart failure, drug-induced edoema, and acute mountain sickness in climbers. Acetazolamide aids altitude adaptation by increasing […]
